{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T23:29:25Z","timestamp":1679873365770},"reference-count":22,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2020]]},"DOI":"10.5797\/jnet.oa.2019-0097","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T22:04:42Z","timestamp":1581458682000},"page":"90-95","source":"Crossref","is-referenced-by-count":2,"title":["The Usefulness of Prasugrel as Rescue Medication in Neuroendovascular Therapy"],"prefix":"10.5797","volume":"14","author":[{"given":"Jun","family":"Niimi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Tasaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tsuruoka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Moriwaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Hatayama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Otake","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Funabashi Municipal Medical Center, Funabashi, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Enomoto Y, Yoshimura S, Sakai N, et al: Current perioperative management of anticoagulant and antiplatelet use in neuroendovascular therapy: analysis of JR-NET1 and 2. <i>Neurol Med Chir (Tokyo)<\/i> 2014; 54: 9\u201316.","DOI":"10.2176\/nmc.oa2013-0160"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kim KS, Fraser JF, Grupke S, et al: Management of antiplatelet therapy in patients undergoing neuroendovascular procedures. <i>J Neurosurg<\/i> 2018; 129: 890\u2013905.","DOI":"10.3171\/2017.5.JNS162307"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fifi JT, Brockington C, Narang J, et al: Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. <i>AJNR Am J Neuroradiol<\/i> 2013; 34: 716\u2013720.","DOI":"10.3174\/ajnr.A3405"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kim B, Kim K, Jeon P, et al: Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. <i>AJNR Am J Neuroradiol<\/i> 2014; 35: 1786\u20131792.","DOI":"10.3174\/ajnr.A3955"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Arimura K, Imamura H, Sakai C, et al: Safety and efficacy of prasugrel with endovascular treatment for unruptured cerebral aneurysm. <i>JNET<\/i> 2017; 11: 553\u2013557.","DOI":"10.5797\/jnet.oa.2017-0047"},{"key":"6","unstructured":"6) Kobayashi N, Mano K: Two cases in-stent thrombosis treated with prasugrel administration: a case report. <i>NKC<\/i> 2017; 2: 6\u201310."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lee D, Song Y, Han M, et al: Low-dose prasugrel in patients with resistance to clopidogrel for the treatment of cerebral aneurysms. <i>Neurointervention<\/i> 2018; 13: 124\u2013127.","DOI":"10.5469\/neuroint.2018.01088"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Goldstein JA: Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. <i>Br J Clin Pharmacol<\/i> 2001; 52: 349\u2013355.","DOI":"10.1046\/j.0306-5251.2001.01499.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Isshiki T, Kimura T, Ogawa H, et al: Prasugrel, a third- generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. <i>Circ J<\/i> 2014; 78: 2926\u20132934.","DOI":"10.1253\/circj.CJ-14-0266"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Umemura K, Iwaki T: The pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy Japanese volunteers. <i>Clin Pharmacol Drug Dev<\/i> 2016; 5: 480\u2013487.","DOI":"10.1002\/cpdd.259"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shuldiner AR, O\u2019Connell JR, Bliden KP, et al: Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. <i>JAMA<\/i> 2009; 302: 849\u2013857.","DOI":"10.1001\/jama.2009.1232"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wiviott SD, Braunwald E, McCabe CH, et al: Prasugrel versus clopidogrel in patients with acute coronary syndromes. <i>N Engl J Med<\/i> 2007; 357: 2001\u20132015.","DOI":"10.1056\/NEJMoa0706482"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Saito S, Isshiki T, Kimura T, et al: Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. <i>Circ J<\/i> 2014; 78: 1684\u20131692.","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nakamura M, Iizuka T, Sagawa K, et al: Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study. <i>Cardiovasc Interv Ther<\/i> 2018; 33: 135\u2013145.","DOI":"10.1007\/s12928-017-0459-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ogawa A, Toyoda K, Kitagawa K, et al: Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I). <i>Lancet Neurol<\/i> 2019; 18: 238\u2013247.","DOI":"10.1016\/S1474-4422(18)30449-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Dobesh PP: Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor. <i>Pharmacotherapy<\/i> 2009; 29: 1089\u20131102.","DOI":"10.1592\/phco.29.9.1089"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mega JL, Close SL, Wiviott SD, et al: Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. <i>Circulation<\/i> 2009; 119: 2553\u20132560.","DOI":"10.1161\/CIRCULATIONAHA.109.851949"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Akbari SH, Reynolds MR, Kadkhodayan Y, et al: Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. <i>J Neurointerv Surg<\/i> 2013; 5: 337\u2013343.","DOI":"10.1136\/neurintsurg-2012-010334"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sedat J, Chau Y, Gaudart J, et al: Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms. <i>Interv Neuroradiol<\/i> 2017; 23: 52\u201359.","DOI":"10.1177\/1591019916669090"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Cho WS, Lee J, Ha EJ, et al: Low-dose prasugrel vs clopidogrel- based tailored premedication for endovascular treatment of cerebral aneurysms. <i>Neurosurgery<\/i> 2019; 85: E52\u2013E59.","DOI":"10.1093\/neuros\/nyy341"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Cagnazzo F, Perrini P, Lefevre PH, et al: Comparison of prasugrel and clopidogrel used as antiplatelet medication for endovascular treatment of unruptured intracranial aneurysms: a meta-analysis. <i>AJNR Am J Neuroradiol<\/i> 2019; 40: 681\u2013686.","DOI":"10.3174\/ajnr.A6004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Xia P, He C, Chen L, et al: Efficacy and safety of prasugrel therapy for intracranial aneurysms with endovascular treatment: a meta-analysis. <i>J Neurol Sci<\/i> 2019; 397: 174\u2013178.","DOI":"10.1016\/j.jns.2019.01.005"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/14\/3\/14_oa.2019-0097\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:32:09Z","timestamp":1584761529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/14\/3\/14_oa.2019-0097\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.oa.2019-0097","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}